Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) as safe …

M Chattopadhyay, CA Velazquez, A Pruski… - … of Pharmacology and …, 2010 - ASPET
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …
被引用次数：37 相关文章
[HTML] nih.gov

[HTML][HTML] Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) …

M Chattopadhyay, CA Velazquez, A Pruski… - The Journal of …, 2010 - ncbi.nlm.nih.gov
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …
[PDF] psu.edu

[PDF][PDF] Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O 2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) as …

M Chattopadhyay, CA Velazquez, A Pruski, KV Nia… - THE JOURNAL OF … - Citeseer
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …

Comparison between 3-nitrooxyphenyl acetylsalicylate (NO-ASA) and O 2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) as safe …

M Chattopadhyay, CA Velazquez… - Journal of …, 2010 - pure.johnshopkins.edu
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …

Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) as safe …

M Chattopadhyay, CA Velazquez… - The Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …
[PDF] researchgate.net

[PDF][PDF] Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O 2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) as …

M Chattopadhyay, CA Velazquez, A Pruski… - THE JOURNAL OF … - researchgate.net
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …

Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) as safe …

M Chattopadhyay, CA Velazquez, A Pruski… - The Journal of …, 2010 - europepmc.org
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …
[PDF] academia.edu

[PDF][PDF] Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O 2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) as …

M Chattopadhyay, CA Velazquez, A Pruski… - THE JOURNAL OF … - academia.edu
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …
[PDF] academia.edu

[PDF][PDF] Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O 2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) as …

M Chattopadhyay, CA Velazquez, A Pruski… - THE JOURNAL OF … - academia.edu
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …

Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl) diazen-1-ium-1, 2-diolate (NONO-ASA) as safe …

M Chattopadhyay, CA Velazquez, A Pruski… - The Journal of …, 2010 - europepmc.org
Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-
inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO …